Company Email Format Management

Opthea

Biotechnology Research Suite 0403, Level 4, 650 Chapel Street 45 employees OPT

Employees: 45
Contacts: 4
Emails: 4
Phones: 4

www.opthea.com LinkedIn Crunchbase

Opthea Overview

Headquarters: Suite 0403, Level 4, 650 Chapel Street
Phone Number: Available in AeroLeads
Website: www.opthea.com
Industry: Biotechnology Research
Employees: 45
Founded: 2012
Stock Symbol: OPT
Funding: 113.3M
Company Email: Available in AeroLeads
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

Keywords

Ophthalmological drug development Retinal Disease Ophthalmology Wet AMD

About Opthea

Opthea (ASX/NASDAQ:OPT) is a biopharmaceutical company developing novel therapies to treat vision-threatening eye diseases, including wet age‐related macular degeneration (wet AMD) and diabetic macular edema (DME), which remain leading causes of vision loss worldwide. Opthea’s lead product candidate in Phase 3 development, sozinibercept, is a first-in-class VEGF-C/D ‘trap’ inhibitor being evaluated in combination with standard-of-care anti-VEGF-A therapies to deliver superior vision to wet AMD patients. Sozinibercept has the potential to become the first therapy in 20 years to enable patients with wet AMD to live fuller and healthier lives.

Opthea Contact Details

People in AeroLeads: 4
With contact data: 4
Email contacts: 4; 100.0% coverage
Phone contacts: 4; 100.0% coverage

Opthea Org Chart

Sample employees and titles

Name	Title	Location	Contact
Susan Orr	Board Member - CEO - CMO	Dallas, Texas, United States	Email Phone
Frederic Guerard		United States	Email Phone
Marcus P. Luscher	Biopharmaceutical Director	Nederland, Colorado, United States	Email Phone
Julie Clark		Santa Monica, California, United States	Email Phone